Back to results
US 2014/0235829 A1Published application
Compositions And Methods For Regulation Of Tumor Necrosis Factor-Alpha
OwnerSoo-Hyun Kim, Charles A. Dinarello +1inventors
InventorsSoo-Hyun Kim, Charles A. Dinarello, Tania Azam
Life of this patent
Estimating the term…
Abstract
The present invention relates to compositions and methods relating to an interleukin 18-inducible cytokine termed tumor necrosis factor-alpha inducing factor (TAIF) or interleukin-32 (IL-32). In particular, the present invention provides compositions and methods for treating autoimmune diseases and cancer, in part by regulation of tumor necrosis factor-alpha expression.
Claims12
1-18. (canceled)
An antibody, which binds to an IL-32 protein.
27-44. (canceled)
Dependencies are inferred from the claim text.